Eli Lilly and Company (LLY): Ken Fisher’s Bet on a Pharma Giant’s Growth Potential
We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to ...
New Atlas4h
Weight-loss pill passes important safety test in clinical trial
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
1 Stubborn Cloud and 2 Silver Linings for Eli Lilly Stock
Despite the above, there are still a couple of silver linings that provide more than enough reason to be bullish about this stock.
Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?
Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...
scmp.com9h
Hong Kong approves celebrity weight-loss drug, but experts say it’s not just to look good
US drug giant Eli Lilly announced last month that Mounjaro, for treating obesity and type 2 diabetes, had been approved by ...
The Motley Fool10h
Is Viking Therapeutics a Buy on the Dip?
Eli Lilly is studying two weight loss candidates in phase 3 trials ... A small player like Viking may also win by attracting ...
Woman Dies After Using Weight-Loss Drug In U.K.’s First Case
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...